Literature DB >> 13106909

Heart force effects of sympathomimetic amines as a basis for their use in shock accompanying myocardial infarction.

P C GAZES, L I GOLDBERG, T D DARBY.   

Abstract

Entities:  

Keywords:  ARTERENOL/therapeutic use; MYOCARDIAL INFARCT/complications; SYMPATHOMIMETICS/therapeutic use

Mesh：

Substances：

Year:  1953        PMID： 13106909     DOI： 10.1161/01.cir.8.6.883

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  9 in total

1.  CLINICAL MANAGEMENT OF ACUTE MYOCARDIAL INFARCTION.

Authors:  F W HURLBURT; J G GILLIS; D KAVANAGH-GRAY; R A PALMER; B SHALLARD; J A TRAYNOR
Journal:  Can Med Assoc J       Date:  1965-08-28       Impact factor: 8.262

2.  Treatment of cardiac shock by metaraminol.

Authors:  E M BESTERMAN
Journal:  Br Med J       Date:  1959-04-25

3.  L-NORADRENALINE.

Authors: 
Journal:  Br Med J       Date:  1956-06-09

4.  Use of pressor agents in shock in myocardial infarction.

Authors:  O GARAI; K S SMITH
Journal:  Br Med J       Date:  1958-02-01

5.  Acute peripheral circulatory failure in surgical cases; treatment with 1-noradrenaline.

Authors:  H D RITCHIE
Journal:  Br Med J       Date:  1956-02-18

Review 6.  Pressor agents.

Authors:  N T Smith
Journal:  Calif Med       Date:  1967-07

7.  Cardiogenic shock.

Authors: 
Journal:  Br Med J       Date:  1966-08-27

Review 8.  Modulation of beta-adrenergic receptor signaling in heart failure and longevity: targeting adenylyl cyclase type 5.

Authors:  David Ho; Lin Yan; Kousaku Iwatsubo; Dorothy E Vatner; Stephen F Vatner
Journal:  Heart Fail Rev       Date:  2010-09       Impact factor: 4.214

9.  Shock Following Myocardial Infarction: A Clinical Survey of 140 Cases.

Authors:  R F Cronin; S Moore; D G Marpole
Journal:  Can Med Assoc J       Date:  1965-07-10       Impact factor: 8.262
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.